Table 5 Pathway enrichment analysis for significant proteins associated with EXOC4 methylation
Gene Set | Description | Size | Expect | Ratio | P value |
|---|---|---|---|---|---|
GO:0,030,101 | NK cell activation | 85 | 0.21814 | 27.505 | 7.13 × 10–04 |
GO:0,042,110 | T cell activation | 452 | 11.600 | 8.6207 | 1.40 × 10–03 |
GO:0,050,673 | Epithelial cell proliferation | 372 | 0.95468 | 9.4272 | 3.10 × 10–03 |
GO:0,002,521 | Leukocyte differentiation | 496 | 12.729 | 7.8560 | 3.30 × 10–03 |
GO:0,070,661 | Leukocyte proliferation | 281 | 0.72115 | 11.093 | 4.54 × 10–03 |
GO:0,001,819 | Positive regulation of cytokine production | 418 | 10.727 | 8.3898 | 8.24 × 10–03 |
GO:0,002,250 | Adaptive immune response | 382 | 0.98035 | 8.1604 | 4.53 × 10–06 |
GO:0,002,285 | Lymphocyte activation involved in immune response | 172 | 0.44141 | 13.593 | 4.57 × 10–06 |
GO:0,018,212 | Peptidyl-tyrosine modification | 389 | 0.99831 | 8.0135 | 5.17 × 10–06 |
GO:0,002,449 | Lymphocyte mediated immunity | 238 | 0.61079 | 9.8233 | 2.9 × 10–05 |